Related references
Note: Only part of the references are listed.Ultrahigh-Resolution Mass Spectrometry-Based Platform for Plasma Metabolomics Applied to Type 2 Diabetes Research
Yanlong Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Systemic Metabolic Alterations Correlate with Islet-Level Prostaglandin E2 Production and Signaling Mechanisms That Predict β-Cell Dysfunction in a Mouse Model of Type 2 Diabetes
Michael D. Schaid et al.
METABOLITES (2021)
Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion
Harpreet K. Sandhu et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)
Agonist-independent Gαz activity negatively regulates beta-cell compensation in a diet-induced obesity model of type 2 diabetes
Michael D. Schaid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk
Ingrid Elisia et al.
PLOS ONE (2020)
Regulation of adipose tissue inflammation by interleukin 6
Myoung Sook Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Quantitative profiling of eicosanoids derived from n-6 and n-3 polyunsaturated fatty acids by twin derivatization strategy combined with LC-MS/MS in patients with type 2 diabetes mellitus
Fangbo Xia et al.
ANALYTICA CHIMICA ACTA (2020)
Evaluation of cyclooxygenase oxylipins as potential biomarker for obesity- associated adipose tissue inflammation and type 2 diabetes using targeted multiple reaction monitoring mass spectrometry
Roel Tans et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2020)
Contribution of Oxidative Stress and Impaired Biogenesis of Pancreatic β-Cells to Type 2 Diabetes
Petr Jezek et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
The role of Cox-2 and prostaglandin E2 receptor EP3 in pancreatic β-cell death
Livnat Amior et al.
FASEB JOURNAL (2019)
Urinary prostaglandin D2 and E2 metabolites associate with abdominal obesity, glucose metabolism, and triglycerides in obese subjects
Sven-Christian Pawelzik et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
Interleukin-6 Reduces β-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response
Michelle R. Marasco et al.
DIABETES (2018)
Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus
Rachel J. Fenske et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Influence of organ donor attributes and preparation characteristics on the dynamics of insulin secretion in isolated human islets
Jean-Claude Henquin
PHYSIOLOGICAL REPORTS (2018)
The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice
Rachel J. Fenske et al.
ENDOCRINOLOGY (2017)
Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy
Amelia K. Linnemann et al.
FASEB JOURNAL (2017)
Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling
Bethany A. Carboneau et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2017)
Opposing effects of prostaglandin E2 receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
Bethany A. Carboneau et al.
MOLECULAR METABOLISM (2017)
The EP3 Receptor/Gz Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular Disease
Michael D. Schaid et al.
AAPS JOURNAL (2017)
cAMP signalling in insulin and glucagon secretion
Anders Tengholm et al.
DIABETES OBESITY & METABOLISM (2017)
Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic -Cell Function
Joshua C. Neuman et al.
DIABETES (2017)
The COX-2/PGE2/EP3/Gi/o/cAMP/GSIS Pathway in the Islet: The Beat Goes On
R. Paul Robertson
DIABETES (2017)
Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic β cells
Jing Wang et al.
CELLULAR SIGNALLING (2016)
The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice
Ryan P. Ceddia et al.
ENDOCRINOLOGY (2016)
Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes
Allison L. Brill et al.
MOLECULAR ENDOCRINOLOGY (2016)
Natural history of β-cell adaptation and failure in type 2 diabetes
Emilyn U. Alejandro et al.
MOLECULAR ASPECTS OF MEDICINE (2015)
Prostaglandin EP3 Receptor Antagonists May Provide Novel Treatment for Diabetes
Ahmed F. Abdel-Magid
ACS Medicinal Chemistry Letters (2015)
A single-islet microplate assay to measure mouse and human islet insulin secretion
Nathan A. Truchan et al.
ISLETS (2015)
Feedback Inhibition of CREB Signaling Promotes Beta Cell Dysfunction in Insulin Resistance
Emilie Blanchet et al.
CELL REPORTS (2015)
Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes
Michelle E. Kimple et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Prostaglandin E2 Receptor, EP3, Is Induced in Diabetic Islets and Negatively Regulates Glucose- and Hormone-Stimulated Insulin Secretion
Michelle E. Kimple et al.
DIABETES (2013)
Deletion of GαZ Protein Protects against Diet-induced Glucose Intolerance via Expansion of β-Cell Mass
Michelle E. Kimple et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cyclooxygenase-2, Not Microsomal Prostaglandin E Synthase-1, Is the Mechanism for Interleukin-1β-induced Prostaglandin E2 Production and Inhibition of Insulin Secretion in Pancreatic Islets
Susan Parazzoli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets
Mauricio da Silva Krause et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Cyclic AMP dynamics in the pancreatic β-cell
Anders Tengholm
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
Body Mass Index of Pancreatic Donors: A Decisive Factor for Human Islet Isolation
Heide Brandhorst et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
The major inflammatory mediator interleukin-6 and obesity
Katalin Eder et al.
INFLAMMATION RESEARCH (2009)
Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion
Oleg Dyachok et al.
CELL METABOLISM (2008)
Glucolipotoxicity:: Fuel excess and β-cell dysfunction
Vincent Poitout et al.
ENDOCRINE REVIEWS (2008)
Interleukin-6 regulates pancreatic α-cell mass expansion
Helga Ellingsgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glucose-induced regulation of COX-2 expression in human islets of langerhans
SJ Persaud et al.
DIABETES (2004)
Role of cyclooxygenase-2 in cytokine-induced β-cell dysfunction and damage by isolated rat and human islets
MR Heitmeier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo
SE Choi et al.
TRANSPLANT IMMUNOLOGY (2004)
Free radicals and the pathogenesis of type 1 diabetes -: β-cell cytokine-mediated free radical generation via cyclooxygenase-2
T Tabatabaie et al.
DIABETES (2003)
CAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
US Jhala et al.
GENES & DEVELOPMENT (2003)
Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion
D Bagga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Overexpression of Gs proteins and adenylyl cyclase in normal and diabetic islets
GM Portela-Gomes et al.
PANCREAS (2002)
Inhibition of interleukin-1β-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet β-cell function
POT Tran et al.
DIABETES (2002)
Share Paper
